On the other hand, the hybrid τP-181/Aβ42 and τT/Aβ42 ratios, although useful in the differential diagnosis of AD [54], including patients with conflicting results [55], may become abnormal due to very low levels of Aβ42 alone, without evidence of tau pathology. The gene discussed is MAPT; the disease is Alzheimer disease.